Australia's largest stock trading and investment forum Australia's #1 stock forum

BUD

0.00%

0.6¢ buddy technologies ltd

Conference/Tweets/Presentations/News, page-767

First 767 Last

Share
Profile

Follow
Gemmax

116 Posts.

5

20/02/19

10:40

Post #: 37496649
Share

Originally posted by Arcturus451: ↑

Yes, hydroponics has absolutely massive potential. The article required a subscription, so I couldn't read most of it, but the potential goes way, way beyond cannabis and it fits beautifully with BUD because it needs lights and constant monitoring. Hydroponics can help overcome the dwindling supply of new arable land because plants can be grown in 3D, rather than just 2D (ie in a series of vertical tiers). Lighting, water, temperature, humidity and nutrients are all crucial and need to be accurately monitored and controlled to maximize yields and profitability.

We're at a tipping point here where you don't have to be a futurist to see the potential for change. The same applies to the home, where it's not hard to see a home in the near future that has an integrated control and monitoring system that handles/monitors/records/actions everything from lights, appliances, security cameras, door locks, heating and cooling, solar power generation, battery storage and balancing (home and car), power both to and from the grid etc. etc. etc. The mind boggles.

So yes, there will be plenty of competition and plenty of room for constant innovation. An M&A meat market and a graveyard! It will be a wild ride, so buckle up and if you can't take the heat, get out of the kitchen!

Expand

http://rootssat.com/
http://rootssat.com/
Arcturus451.

I have to agree hydro is massive. If interested. Google "Roots Sustainable Technologies" Disclosure. Held.
They are developing the tech. Perhaps a good fit for Buddy to monitor.

http://rootssat.com/

BUD Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN